Analyze Diet
Veterinary microbiology1992; 32(3-4); 215-228; doi: 10.1016/0378-1135(92)90146-k

Immune responses of specific pathogen free foals to EHV-1 infection.

Abstract: Four foals were raised under specific pathogen free (SPF) conditions. At 3 to 4 months of age, SPF foals and 1 other non-SPF foal were intranasally inoculated with equine herpes virus type 1 (EHV-1). Clinical signs included depression, fever, inappetence and intermittent coughing. Clinical recovery was complete by seven days but high titres of virus were detected in nasal mucus for at least 10 days after inoculation. Clinical illness was less severe in the non-SPF foal. Interferon was detected in the nasal mucus of all foals from 2 days post infection (dpi), persisting until 8 or 10 dpi. ELISA antibody was detected in serum from 6 dpi. Titres continued to rise throughout the period of observation, and were slightly stimulated by re-inoculation. EHV antibody, identified as belonging to the IgM class by the double sandwich ELISA, was detected from 6 dpi. Peak IgM titres were observed between day 10 and 18, declining to base levels by day 42. Virus neutralizing antibody was detectable in serum from day 14 and rises in titre were parallel to that of total ELISA antibody. Cellular immunity in EHV-1 infected SPF horses was examined by the antibody dependent cytotoxicity (ADCC) test and the specific lymphocyte transformation test. The ability of foal neutrophils to effect ADCC decreased significantly between 3 to 10 days after inoculation. Peripheral blood mononuclear cells (PBMC) displayed reactivity towards EHV-1 antigens from about day 14, with maximum stimulation indices being obtained between 28 and 42 dpi.
Publication Date: 1992-10-01 PubMed ID: 1280876DOI: 10.1016/0378-1135(92)90146-kGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article examines the immune responses of foals, raised under specific pathogen free (SPF) conditions, to equine herpes virus type 1 (EHV-1) infection. The study found that the virus induced symptoms that recovered within seven days, but stayed detectable in nasal mucus for at least 10 days. The SPF foals’ immune systems responded by producing interferon, antibodies, and other immune responses.

Experiment Design and Findings

  • Four foals were raised under SPF conditions and another non-SPF foal were inoculated with EHV-1 when they were 3 to 4 months old. This was to investigate their immune responses when exposed to a specific pathogen like EHV-1.
  • Post-infection, the foals exhibited clinical signs such as depression, fever, inappetence, and coughing, which completed recovery in seven days. However, the virus remained detectable in the nasal mucus for at least 10 days after inoculation, indicating that though clinical signs had resolved, the virus was still present in their bodies.
  • The clinical illness was less severe in the non-SPF foal, implying that exposure to various pathogens prior to the study may have fortified the foal’s immune system.

Immune Responses to EHV-1 Infection

  • Interferon, a protein that the immune system produces in response to viral infections, was detected in all the foals from 2 days post infection (dpi), demonstrating an immediate response to the virus.
  • Antibodies, identified by ELISA testing, rose in serum from 6 dpi and continued rising throughout the observation period. They were stimulated more by re-inoculation, suggesting that the immune system adjusts its response based on the severity of the viral attack.
  • The study also noted a rise in virus neutralizing antibodies from day 14, which increased parallelly to the total ELISA antibody, implying simultaneous development of specific and broad-spectrum immune responses against the virus.

Analysis of Cellular Immunity

  • Cellular immunity was analyzed using the Antibody Dependent Cytotoxicity (ADCC) test and a specific lymphocyte transformation test. These tests revealed that the ability of foal neutrophils to effect ADCC decreased significantly between 3 to 10 days after inoculation. This indicates that the initial robust immune response could be reducing with time or as the body “learns” to manage the infection.
  • Peripheral blood mononuclear cells (PBMC), a type of immune cell, showed reactivity to EHV-1 antigens from day 14, peaking between 28 and 42 dpi. This suggests that the body’s cellular immunity takes some time to mount a full response, but when it does, it can effectively fight the virus.

Cite This Article

APA
Chong YC, Duffus WP. (1992). Immune responses of specific pathogen free foals to EHV-1 infection. Vet Microbiol, 32(3-4), 215-228. https://doi.org/10.1016/0378-1135(92)90146-k

Publication

ISSN: 0378-1135
NlmUniqueID: 7705469
Country: Netherlands
Language: English
Volume: 32
Issue: 3-4
Pages: 215-228

Researcher Affiliations

Chong, Y C
  • Department of Clinical Veterinary Medicine, Cambridge, UK.
Duffus, W P

    MeSH Terms

    • Animals
    • Antibodies, Viral / biosynthesis
    • Antibodies, Viral / blood
    • Antibody-Dependent Cell Cytotoxicity
    • Cross Reactions
    • Enzyme-Linked Immunosorbent Assay
    • Herpesviridae Infections / immunology
    • Herpesviridae Infections / veterinary
    • Herpesvirus 1, Equid / immunology
    • Horse Diseases / immunology
    • Horses
    • Immunoglobulin M / biosynthesis
    • Immunoglobulin M / blood
    • Interferons / blood
    • Lymphocyte Activation
    • Neutralization Tests
    • Neutrophils / immunology
    • Specific Pathogen-Free Organisms

    Citations

    This article has been cited 7 times.
    1. Laval K, Poelaert KCK, Van Cleemput J, Zhao J, Vandekerckhove AP, Gryspeerdt AC, Garré B, van der Meulen K, Baghi HB, Dubale HN, Zarak I, Van Crombrugge E, Nauwynck HJ. The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1. Front Microbiol 2021;12:662686.
      doi: 10.3389/fmicb.2021.662686pubmed: 33746936google scholar: lookup
    2. Detournay O, Morrison DA, Wagner B, Zarnegar B, Wattrang E. Genomic analysis and mRNA expression of equine type I interferon genes. J Interferon Cytokine Res 2013 Dec;33(12):746-59.
      doi: 10.1089/jir.2012.0130pubmed: 23772953google scholar: lookup
    3. Jensen-Waern M, Persson SG, Nordengrahn A, Mérza M, Fossum C. Temporary suppression of cell-mediated immunity in standardbred horses with decreased athletic capacity. Acta Vet Scand 1998;39(1):25-33.
      doi: 10.1186/BF03547804pubmed: 9592943google scholar: lookup
    4. Sutton GA, Viel L, Carman PS, Boag BL. Pathogenesis and clinical signs of equine herpesvirus-1 in experimentally infected ponies in vivo. Can J Vet Res 1998 Jan;62(1):49-55.
      pubmed: 9442940
    5. Nishimura F, Fukushi N, Sakai H, Fukushi H. Attenuation of the neuropathogenic equine herpesvirus type 1 strain Ab4p in hamsters by a single amino acid mutation (D752N) in viral DNA polymerase ORF30. J Vet Med Sci 2024 Dec 1;86(12):1273-1278.
      doi: 10.1292/jvms.24-0338pubmed: 39384384google scholar: lookup
    6. Holmes CM, Babasyan S, Eady N, Schnabel CL, Wagner B. Immune horses rapidly increase antileukoproteinase and lack type I interferon secretion during mucosal innate immune responses against equine herpesvirus type 1. Microbiol Spectr 2024 Oct 3;12(10):e0109224.
      doi: 10.1128/spectrum.01092-24pubmed: 39162558google scholar: lookup
    7. Giessler KS, Goehring LS, Jacob SI, Davis A, Esser MM, Lee Y, Zarski LM, Weber PSD, Hussey GS. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses. J Gen Virol 2024 May;105(5).
      doi: 10.1099/jgv.0.001987pubmed: 38767608google scholar: lookup